Teamwork Financial Advisors LLC Lowers Stock Holdings in Astera Labs, Inc. $ALAB

Posted by George Bondi on Aug 8th, 2026

Teamwork Financial Advisors LLC cut its position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 37.6% in the second quarter, HoldingsChannel reports. The institutional investor owned 3,959 shares of the company’s stock after selling 2,382 shares during the period. Teamwork Financial Advisors LLC’s holdings in Astera Labs were worth $1,912,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. PensionDanmark Pensionsforsikringsaktieselskab raised its holdings in shares of Astera Labs by 8.3% in the 2nd quarter. PensionDanmark Pensionsforsikringsaktieselskab now owns 11,350 shares of the company’s stock valued at $5,482,000 after buying an additional 870 shares during the period. Assenagon Asset Management S.A. purchased a new position in Astera Labs during the 2nd quarter valued at about $3,658,000. Thrive Wealth Management LLC purchased a new position in Astera Labs during the 2nd quarter valued at about $290,000. Mirador Capital Partners LP acquired a new position in Astera Labs in the 2nd quarter valued at about $5,684,000. Finally, Dynamic Advisor Solutions LLC acquired a new position in Astera Labs in the 2nd quarter valued at about $306,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,244,395 shares of company stock worth $358,865,571. 10.40% of the stock is currently owned by company insiders.

Astera Labs Trading Up 0.8%

Shares of ALAB stock opened at $334.17 on Friday. The firm has a fifty day moving average price of $360.45 and a 200 day moving average price of $235.27. The company has a market cap of $57.98 billion, a P/E ratio of 165.43, a PEG ratio of 3.84 and a beta of 3.84. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 1.86 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently issued reports on ALAB shares. Susquehanna increased their price target on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Roth Capital restated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday. Stifel Nicolaus upped their target price on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Morgan Stanley increased their target price on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday. Finally, Bank of America raised their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $325.25.

Check Out Our Latest Report on ALAB

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.